comparemela.com

Latest Breaking News On - Savin scale - Page 1 : comparemela.com

Kintor Pharma says alopecia primary endpoint met

Kintor Pharma has announced results of a phase II clinical trial for its potential topical drug to treat adult female androgeneticalopecia.

Kintor pharmaJianzhong zhangKintor pharmaceuticalDepartment of dermatologyUniversity people hospitalKintor pharmaceutical limitedPeking university peopleSavin scale

Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826 s Treatment of Female Androgenetic Alopecia in China Was Met

DJ Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826's Treatment of Female Androgenetic Alopecia in China Was Met EQS Newswire / 02/12/2022 / 10:34 UTC+8 Kintor

Kintor pharmaJianzhong zhangFinancial pressKintor pharmaceuticalDepartment of dermatologyUniversity people hospitalKintor pharmaceutical limited pharmaPharma announcedPrimary endpointFemale androgenetic alopeciaChina was metPharmaceutical limitedPeking university peopleSavin scaleYouzhi tongChief executive officer

Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826 s Treatment of Female Androgenetic Alopecia in China Was Met

/PRNewswire/ Kintor Pharmaceutical Limited ("KintorPharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and.

Kintor pharmaJianzhong zhangKintor pharmaceutical limited kintorpharmaDepartment of dermatologyUniversity people hospitalKintor pharmaceutical limitedPeking university peopleSavin scaleYouzhi tongChief executive officer

vimarsana © 2020. All Rights Reserved.